Literature DB >> 22456983

Breast cancer incidence trends in European women aged 20-39 years at diagnosis.

D F Merlo1, M Ceppi, R Filiberti, V Bocchini, A Znaor, M Gamulin, M Primic-Žakelj, P Bruzzi, C Bouchardy, A Fucic.   

Abstract

An increase in the incidence of breast cancer in women aged<40 years has been reported in recent years. Increased incidence could be partly explained by subtle detection biases, but the role of other risk factors cannot be ruled out. The purpose of the present study was to investigate the changes in temporal trends in breast cancer incidence in European women aged 20-39 years at diagnosis. Age specific breast cancer incidence rates for 17 European Cancer Registries were retrieved for the calendar period 1995-2006. Cancer registries data were pooled to reduce annual fluctuations present in single registries and increase incidence rates stability. Regression models were fitted to the data assuming that the number of cancer cases followed the Poisson distribution. Mean annual changes in the incidence rate (AIC) across the considered time window were calculated. The AIC estimated from all European registries was 1.032 (95% CI=1.019-1.045) and 1.014 (95% CI=1.010-1.018) in women aged 20-29 and 30-39 years old at diagnosis, respectively. The major change was detected among women aged 25-29 years at diagnosis: AIC=1.033 (95% CI=1.020-1.046). The upward trend was not affected when registries with high or low AIC were removed from the analysis (sensitivity analysis). Our findings support the presence of an increase in the incidence of breast cancer in European women in their 20s and 30s during the decade 1995-2006. The interpretation of the observed increase is not straightforward since a number of factors may have affected our results. The estimated annual increase in breast cancer incidence may result in a burden of the disease that is important in terms of public health and deserves further investigation of possible risk factors.

Entities:  

Mesh:

Year:  2012        PMID: 22456983     DOI: 10.1007/s10549-012-2031-7

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  27 in total

1.  Breast Carcinoma in Young Women: No Evidence of Increasing Rates of Metastatic Breast Carcinoma in a Single Tertiary Center Review.

Authors:  Niamh Conlon; Jane Howard; Jeffrey Catalano; Meighan Gallagher; Lee K Tan; Adriana D Corben
Journal:  Breast J       Date:  2016-02-29       Impact factor: 2.431

2.  Age-standardized cancer-incidence trends in Canada, 1971-2015.

Authors:  Darren R Brenner; Yibing Ruan; Eileen Shaw; Dylan O'Sullivan; Abbey E Poirier; Emily Heer; Paul J Villeneuve; Stephen D Walter; Christine M Friedenreich; Leah Smith; Prithwish De
Journal:  CMAJ       Date:  2019-11-18       Impact factor: 8.262

3.  Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.

Authors:  X Sun; C Xu; S-C Tang; J Wang; H Wang; P Wang; N Du; S Qin; G Li; S Xu; Z Tao; Dapeng Liu; H Ren
Journal:  Cancer Gene Ther       Date:  2016-03-18       Impact factor: 5.987

Review 4.  IVF for fertility preservation in breast cancer patients--efficacy and safety issues.

Authors:  M Shapira; H Raanani; D Meirow
Journal:  J Assist Reprod Genet       Date:  2015-07-01       Impact factor: 3.412

Review 5.  Issues with Fertility in Young Women with Breast Cancer.

Authors:  Nicole Christian; Mary L Gemignani
Journal:  Curr Oncol Rep       Date:  2019-05-16       Impact factor: 5.075

6.  Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.

Authors:  E Martín-Sánchez; E Pernaut-Leza; S Mendaza; A Cordoba; F Vicente-Garcia; I Monreal-Santesteban; J Pérez Vizcaino; M J Díaz De Cerio; N Perez-Janices; I Blanco-Luquin; D Escors; A Ulazia-Garmendia; D Guerrero-Setas
Journal:  Virchows Arch       Date:  2016-04-21       Impact factor: 4.064

7.  Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?

Authors:  Angelena Crown; Shirin Muhsen; Emily C Zabor; Varadan Sevilimedu; Joanne Kelvin; Shari B Goldfarb; Mary L Gemignani
Journal:  Ann Surg Oncol       Date:  2020-08-07       Impact factor: 5.344

8.  Fertility counseling of young breast cancer patients.

Authors:  Matteo Lambertini; Paola Anserini; Alessia Levaggi; Francesca Poggio; Lucia Del Mastro
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

9.  Comparative hematological profiles for dose-dense vs. regular anthracycline-based neoadjuvant chemotherapy in non-metastatic breast cancer.

Authors:  Dorel Popovici; Cristina Oprean; Sorin Săftescu; Alina Negru; Mihnea Munteanu; Horia T Stanca; Adrian Teodoru; Simona Stanca; Șerban Negru
Journal:  Exp Ther Med       Date:  2021-05-11       Impact factor: 2.447

10.  Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification.

Authors:  Holger Fröhlich; Sabyasachi Patjoshi; Kristina Yeghiazaryan; Christina Kehrer; Walther Kuhn; Olga Golubnitschaja
Journal:  EPMA J       Date:  2018-04-11       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.